Brief: Accuray Says Cyberknife Robotic Radiotherapy Platform Is Superior To Conventional Linear Accelerators

Accuray

14/09/2021 12:36

Sept 14 (Reuters) - Accuray Inc  ARAY.O :
    * ACCURAY - CYBERKNIFE ROBOTIC RADIOTHERAPY PLATFORM IS
SUPERIOR
TO CONVENTIONAL LINEAR ACCELERATORS IN REDUCING INCIDENCE OF
BLADDER SIDE EFFECTS IN PROSTATE CANCER PATIENTS
    * ACCURAY INC - PROSPECTIVE, RANDOMIZED, INTERNATIONAL
MULTICENTER
STUDY - PROSTATE ADVANCES IN COMPARATIVE EVIDENCE RESULTS
PRESENTED AT ESTRO 2021

Source text for Eikon:  ID:nPn3L9MWQa 
Further company coverage:  ARAY.O 

 ((Reuters.Briefs@thomsonreuters.com;))